Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial

2005/06/29 by Mary Beth O’Connell, Denyse M. Madden, Anne M. Murray +2 · 28 citations
Medicine · #Bone health and osteoporosis research #Vitamin D Research Studies #Renal function and acid-base balance

paper · doi:10.1016/j.amjmed.2005.02.007

Cited by

• The Relationship Between Proton Pump Inhibitor Use and Longitudinal Change in Bone Mineral Density: A Population-Based From the Canadian Multicentre Osteoporosis Study (CaMos)
• The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
• Proton Pump Inhibitors: Review of Emerging Concerns
• Activation of the calcium sensing receptor stimulates gastrin and gastric acid secretion in healthy participants. [europepmc]
• Acid-suppressive medications and risk of bone loss and fracture in older adults. [europepmc]
• Hip fracture risk in patients with a diagnosis of pernicious anemia. [europepmc]
• Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. [europepmc]
• Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. [europepmc]
• Do proton pump inhibitors decrease calcium absorption? [europepmc]
• Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. [europepmc]
• Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. [europepmc]
• Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. [europepmc]
• Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. [europepmc]
• The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). [europepmc]
• The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. [europepmc]
• Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. [europepmc]
• Chronic proton pump inihibitor therapy and calcium metabolism. [europepmc]
• A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study. [europepmc]
• Use of proton pump inhibitors is associated with fractures in young adults: a population-based study. [europepmc]
• The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. [europepmc]
• A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors. [europepmc]
• Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. [europepmc]
• Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis. [europepmc]
• Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved. [europepmc]
• Adverse Effects of Proton Pump Inhibitors-Evidence and Plausibility. [europepmc]
• Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study. [europepmc]
• Polypharmacy and Malnutrition Management of Elderly Perioperative Patients with Cancer: A Systematic Review. [europepmc]
• Proton Pump Inhibitors and Bone Health: An Update Narrative Review. [europepmc]